A detailed history of Opes Wealth Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Opes Wealth Management LLC holds 20,392 shares of BMY stock, worth $1.2 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
20,392
Previous 20,533 0.69%
Holding current value
$1.2 Million
Previous $852,000 23.83%
% of portfolio
0.21%
Previous 0.18%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$39.66 - $51.75 $5,592 - $7,296
-141 Reduced 0.69%
20,392 $1.06 Million
Q2 2024

Aug 05, 2024

BUY
$40.25 - $52.99 $4,548 - $5,987
113 Added 0.55%
20,533 $852,000
Q1 2024

May 02, 2024

SELL
$47.98 - $54.4 $9,452 - $10,716
-197 Reduced 0.96%
20,420 $1.11 Million
Q4 2023

Jan 31, 2024

SELL
$48.48 - $57.85 $5,963 - $7,115
-123 Reduced 0.59%
20,617 $1.06 Million
Q3 2023

Nov 02, 2023

BUY
$57.89 - $64.73 $7,178 - $8,026
124 Added 0.6%
20,740 $1.2 Million
Q2 2023

Aug 02, 2023

BUY
$63.71 - $70.74 $1,911 - $2,122
30 Added 0.15%
20,616 $1.32 Million
Q1 2023

May 01, 2023

BUY
$65.71 - $74.53 $49,348 - $55,972
751 Added 3.79%
20,586 $1.43 Million
Q4 2022

Jan 30, 2023

SELL
$68.48 - $81.09 $13,969 - $16,542
-204 Reduced 1.02%
19,835 $1.43 Million
Q3 2022

Oct 31, 2022

BUY
$0.13 - $76.84 $2,605 - $1.54 Million
20,039 New
20,039 $1.43 Million
Q1 2022

May 05, 2022

SELL
$61.48 - $73.72 $234,484 - $281,168
-3,814 Closed
0 $0
Q4 2021

Jan 31, 2022

BUY
$53.63 - $62.52 $204,544 - $238,451
3,814 New
3,814 $238,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Opes Wealth Management LLC Portfolio

Follow Opes Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opes Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Opes Wealth Management LLC with notifications on news.